Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214301919> ?p ?o ?g. }
- W2214301919 endingPage "2731" @default.
- W2214301919 startingPage "2723" @default.
- W2214301919 abstract "Propionibacterium acnes induction of IL-1 cytokines through the NLRP3 (NLR, nucleotide oligomerization domain-like receptor) inflammasome was recently highlighted as a dominant etiological factor for acne vulgaris. Therefore, therapeutics targeting both the stimulus and the cascade would be ideal. Nitric oxide (NO), a potent biological messenger, has documented broad-spectrum antimicrobial and immunomodulatory properties. To harness these characteristics to target acne, we used an established nanotechnology capable of generating/releasing NO over time (NO-np). P. acnes was found to be highly sensitive to all concentrations of NO-np tested, although human keratinocyte, monocyte, and embryonic zebra fish assays revealed no cytotoxicity. NO-np significantly suppressed IL-1β, tumor necrosis factor-α (TNF-α), IL-8, and IL-6 from human monocytes, and IL-8 and IL-6 from human keratinocytes, respectively. Importantly, silencing of NLRP3 expression by small interfering RNA did not limit NO-np inhibition of IL-1 β secretion from monocytes, and neither TNF-α nor IL-6 secretion, nor inhibition by NO-np was found to be dependent on this pathway. The observed mechanism by which NO-np impacts IL-1β secretion was through inhibition of caspase-1 and IL-1β gene expression. Together, these data suggest that NO-np can effectively prevent P. acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. Propionibacterium acnes induction of IL-1 cytokines through the NLRP3 (NLR, nucleotide oligomerization domain-like receptor) inflammasome was recently highlighted as a dominant etiological factor for acne vulgaris. Therefore, therapeutics targeting both the stimulus and the cascade would be ideal. Nitric oxide (NO), a potent biological messenger, has documented broad-spectrum antimicrobial and immunomodulatory properties. To harness these characteristics to target acne, we used an established nanotechnology capable of generating/releasing NO over time (NO-np). P. acnes was found to be highly sensitive to all concentrations of NO-np tested, although human keratinocyte, monocyte, and embryonic zebra fish assays revealed no cytotoxicity. NO-np significantly suppressed IL-1β, tumor necrosis factor-α (TNF-α), IL-8, and IL-6 from human monocytes, and IL-8 and IL-6 from human keratinocytes, respectively. Importantly, silencing of NLRP3 expression by small interfering RNA did not limit NO-np inhibition of IL-1 β secretion from monocytes, and neither TNF-α nor IL-6 secretion, nor inhibition by NO-np was found to be dependent on this pathway. The observed mechanism by which NO-np impacts IL-1β secretion was through inhibition of caspase-1 and IL-1β gene expression. Together, these data suggest that NO-np can effectively prevent P. acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. multiplicity of infection nitric oxide nanoparticle nucleotide oligomerization domain-like receptor peripheral blood mononuclear cell small interfering RNA tumor necrosis factor-α" @default.
- W2214301919 created "2016-06-24" @default.
- W2214301919 creator A5000221161 @default.
- W2214301919 creator A5001312410 @default.
- W2214301919 creator A5008321696 @default.
- W2214301919 creator A5014641708 @default.
- W2214301919 creator A5020614380 @default.
- W2214301919 creator A5022857099 @default.
- W2214301919 creator A5026274771 @default.
- W2214301919 creator A5038980736 @default.
- W2214301919 creator A5047439189 @default.
- W2214301919 creator A5052929919 @default.
- W2214301919 creator A5058344594 @default.
- W2214301919 creator A5069450479 @default.
- W2214301919 creator A5070349245 @default.
- W2214301919 creator A5071540090 @default.
- W2214301919 creator A5080830504 @default.
- W2214301919 creator A5082902741 @default.
- W2214301919 creator A5087656849 @default.
- W2214301919 date "2015-11-01" @default.
- W2214301919 modified "2023-10-18" @default.
- W2214301919 title "Nitric Oxide–Releasing Nanoparticles Prevent Propionibacterium acnes– Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response" @default.
- W2214301919 cites W1269597682 @default.
- W2214301919 cites W1526743142 @default.
- W2214301919 cites W166147258 @default.
- W2214301919 cites W1968881433 @default.
- W2214301919 cites W1970609251 @default.
- W2214301919 cites W1972474426 @default.
- W2214301919 cites W1982996309 @default.
- W2214301919 cites W1985289402 @default.
- W2214301919 cites W1989079107 @default.
- W2214301919 cites W1995079346 @default.
- W2214301919 cites W2009004909 @default.
- W2214301919 cites W2011672764 @default.
- W2214301919 cites W2012109766 @default.
- W2214301919 cites W2014716916 @default.
- W2214301919 cites W2020522743 @default.
- W2214301919 cites W2033040828 @default.
- W2214301919 cites W2041464737 @default.
- W2214301919 cites W2057860005 @default.
- W2214301919 cites W2073101615 @default.
- W2214301919 cites W2073143004 @default.
- W2214301919 cites W2073152269 @default.
- W2214301919 cites W2074413041 @default.
- W2214301919 cites W2081164178 @default.
- W2214301919 cites W2081485204 @default.
- W2214301919 cites W2082684919 @default.
- W2214301919 cites W2124178650 @default.
- W2214301919 cites W2130959526 @default.
- W2214301919 cites W2133051117 @default.
- W2214301919 cites W2146650664 @default.
- W2214301919 cites W2155226168 @default.
- W2214301919 cites W2165002516 @default.
- W2214301919 cites W2165985796 @default.
- W2214301919 cites W2167327196 @default.
- W2214301919 cites W2171863770 @default.
- W2214301919 cites W2173833672 @default.
- W2214301919 cites W2246968971 @default.
- W2214301919 cites W2418418828 @default.
- W2214301919 cites W4211217520 @default.
- W2214301919 cites W4243141379 @default.
- W2214301919 doi "https://doi.org/10.1038/jid.2015.277" @default.
- W2214301919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4640998" @default.
- W2214301919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26172313" @default.
- W2214301919 hasPublicationYear "2015" @default.
- W2214301919 type Work @default.
- W2214301919 sameAs 2214301919 @default.
- W2214301919 citedByCount "36" @default.
- W2214301919 countsByYear W22143019192015 @default.
- W2214301919 countsByYear W22143019192016 @default.
- W2214301919 countsByYear W22143019192017 @default.
- W2214301919 countsByYear W22143019192018 @default.
- W2214301919 countsByYear W22143019192019 @default.
- W2214301919 countsByYear W22143019192020 @default.
- W2214301919 countsByYear W22143019192021 @default.
- W2214301919 countsByYear W22143019192022 @default.
- W2214301919 countsByYear W22143019192023 @default.
- W2214301919 crossrefType "journal-article" @default.
- W2214301919 hasAuthorship W2214301919A5000221161 @default.
- W2214301919 hasAuthorship W2214301919A5001312410 @default.
- W2214301919 hasAuthorship W2214301919A5008321696 @default.
- W2214301919 hasAuthorship W2214301919A5014641708 @default.
- W2214301919 hasAuthorship W2214301919A5020614380 @default.
- W2214301919 hasAuthorship W2214301919A5022857099 @default.
- W2214301919 hasAuthorship W2214301919A5026274771 @default.
- W2214301919 hasAuthorship W2214301919A5038980736 @default.
- W2214301919 hasAuthorship W2214301919A5047439189 @default.
- W2214301919 hasAuthorship W2214301919A5052929919 @default.
- W2214301919 hasAuthorship W2214301919A5058344594 @default.
- W2214301919 hasAuthorship W2214301919A5069450479 @default.
- W2214301919 hasAuthorship W2214301919A5070349245 @default.
- W2214301919 hasAuthorship W2214301919A5071540090 @default.
- W2214301919 hasAuthorship W2214301919A5080830504 @default.
- W2214301919 hasAuthorship W2214301919A5082902741 @default.
- W2214301919 hasAuthorship W2214301919A5087656849 @default.
- W2214301919 hasBestOaLocation W22143019191 @default.
- W2214301919 hasConcept C136449434 @default.
- W2214301919 hasConcept C17991360 @default.